ROCÍO
GARCÍA CARBONERO
Profesora asociada de Ciencias de la Salud
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublications en collaboration avec des chercheurs de Hospital Clínico Universitario Lozano Blesa (9)
2021
2019
-
Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 37, Núm. 28, pp. 2571-2580
2017
2015
-
Pazopanib in pretreated advanced neuroendocrine tumors: A phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)
Annals of Oncology, Vol. 26, Núm. 9, pp. 1987-1993
2011
-
SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours (GEP NETS)
Clinical and Translational Oncology, Vol. 13, Núm. 8, pp. 545-551
2010
-
SEOM clinical guidelines for the treatment of advanced colorectal cancer
Clinical and Translational Oncology, Vol. 12, Núm. 11, pp. 729-734
2008
-
Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer
Clinical and Translational Oncology, Vol. 10, Núm. 1, pp. 52-57
2006
-
Polymorphisms in DNA repair genes modulate survival in cisplatin/ gemcitabine-treated non-small-cell lung cancer patients
Annals of Oncology, Vol. 17, Núm. 4, pp. 668-675
2001
-
Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: A multicenter randomized trial
Journal of the National Cancer Institute, Vol. 93, Núm. 1, pp. 31-38